T1	disease_or_phenotypic_feature 64 71	pan-RAF
T2	chemical 72 81	inhibitor
T3	disease_or_phenotypic_feature 99 116	colorectal cancer
T4	chemical 172 182	phosphorus
T5	chemical 207 214	calcium
T6	chemical 235 243	solution
T7	disease_or_phenotypic_feature 287 300	hypercalcemia
T8	disease_or_phenotypic_feature 305 321	hypophosphatemia
T9	chemical 402 412	inhibitors
T10	disease_or_phenotypic_feature 452 464	hypertensive
T11	disease_or_phenotypic_feature 465 478	heart failure
T12	chemical 489 503	Growth hormone
T13	disease_or_phenotypic_feature 516 529	short stature
T14	disease_or_phenotypic_feature 533 556	Diamond Blackfan anemia
T15	chemical 558 567	Fulminant
T16	disease_or_phenotypic_feature 568 613	Reversible Cerebral Vasoconstriction Syndrome
T17	chemical 730 737	glucose
T18	disease_or_phenotypic_feature 755 768	hyperglycemia
T19	disease_or_phenotypic_feature 769 785	hyperinsulinemia
T20	chemical 808 815	antigen
T21	disease_or_phenotypic_feature 817 826	cirrhosis
T22	disease_or_phenotypic_feature 831 839	hepatoma
T23	chemical 854 857	Ten
T24	disease_or_phenotypic_feature 902 909	obesity
T25	chemical 918 926	hormones
T26	chemical 1047 1059	pioglitazone
T27	disease_or_phenotypic_feature 1072 1086	bladder cancer
T28	chemical 1183 1187	drug
T29	disease_or_phenotypic_feature 1210 1224	ovarian cancer
T30	disease_or_phenotypic_feature 1226 1243	colorectal cancer
T31	disease_or_phenotypic_feature 1249 1263	gastric cancer
T32	chemical 1290 1294	talc
T33	disease_or_phenotypic_feature 1337 1354	ovarian carcinoma
T34	chemical 1440 1450	inhibitors
T35	chemical 1451 1460	erlotinib
T36	chemical 1465 1474	gefitinib
T37	disease_or_phenotypic_feature 1540 1546	mutant
T38	corrected_chemical 1646 1649	MPa
T39	chemical 1651 1662	"ARG4.0MPa"
T40	disease_or_phenotypic_feature 1651 1662	"ARG4.0MPa"
T41	chemical 1682 1695	Teneligliptin
T42	disease_or_phenotypic_feature 1732 1739	obesity
T43	disease_or_phenotypic_feature 1744 1751	obesity
T44	disease_or_phenotypic_feature 1763 1782	metabolic disorders
T45	chemical 1784 1795	Biochemical
T46	disease_or_phenotypic_feature 1807 1815	cataract
T47	chemical 1847 1857	fatty acid
T48	chemical 1858 1866	epoxides
T49	chemical 1903 1906	fat
T50	disease_or_phenotypic_feature 1920 1927	obesity
T51	disease_or_phenotypic_feature 1984 1991	obesity
T52	disease_or_phenotypic_feature 2049 2054	tumor
T53	chemical 2104 2113	molecular
T54	disease_or_phenotypic_feature 2188 2194	cancer
T55	chemical 2234 2238	drug
T56	chemical 2310 2318	antigens
T57	disease_or_phenotypic_feature 2361 2368	cancers
T58	chemical 2406 2414	antigens
T59	chemical 2437 2448	Angiotensin
T60	chemical 2460 2466	enzyme
T61	chemical 2473 2483	inhibitors
T62	disease_or_phenotypic_feature 2550 2574	congestive heart failure
T63	disease_or_phenotypic_feature 2594 2614	diabetic nephropathy
T64	corrected_chemical 64 81	pan-RAF inhibitor
T65	corrected_chemical 398 412	ACE inhibitors
R3	treats Arg1:T12 Arg2:T13	
R4	treats Arg1:T12 Arg2:T14	
T66	missed_disease_or_phenotypic_feature 647 668	Asymptomatic Stenosis
T67	corrected_disease_or_phenotypic_feature 558 613	Fulminant Reversible Cerebral Vasoconstriction Syndrome
T68	corrected_disease_or_phenotypic_feature 755 785	hyperglycemia-hyperinsulinemia
T69	missed_disease_or_phenotypic_feature 787 796	Hepatitis
T70	missed_chemical 911 926	stress hormones
R5	treats Arg1:T26 Arg2:T27	
T71	missed_chemical 1148 1160	chemotherapy
T72	corrected_chemical 1282 1294	Genital talc
T73	missed_chemical 1412 1416	EGFR
T74	missed_disease_or_phenotypic_feature 1495 1500	tumor
R7	treats Arg1:T41 Arg2:T42	
T79	missed_chemical 1951 1954	LMs
T80	missed_disease_or_phenotypic_feature 2174 2183	infection
T82	missed_disease_or_phenotypic_feature 2251 2257	tumors
T83	missed_disease_or_phenotypic_feature 2304 2309	tumor
T85	missed_disease_or_phenotypic_feature 2576 2588	hypertension
T87	DONE 2616 2620	DONE
R12	treats Arg1:T64 Arg2:T3	
T88	missed_chemical 0 9	LY3214996
R13	treats Arg1:T88 Arg2:T3	
T89	missed_disease_or_phenotypic_feature 374 396	impaired mental status
T90	corrected_disease_or_phenotypic_feature 452 478	hypertensive heart failure
R17	treats Arg1:T65 Arg2:T90	
T91	missed_disease_or_phenotypic_feature 1744 1783	obesity-associated metabolic disorders.
R8	treats Arg1:T41 Arg2:T91	
T92	corrected_chemical 2278 2318	Immunization with defined tumor antigens
R21	treats Arg1:T92 Arg2:T57	
T93	corrected_chemical 1132 1167	intraperitoneal chemotherapy agents
R16	treats Arg1:T93 Arg2:T29	
R18	treats Arg1:T93 Arg2:T30	
R22	treats Arg1:T93 Arg2:T31	
T94	corrected_chemical 1425 1450	small molecule inhibitors
T95	corrected_chemical 2437 2466;2473 2483	Angiotensin converting-enzyme inhibitors
R6	causes_or_contributes_to Arg1:T32 Arg2:T33	
T96	missed_disease_or_phenotypic_feature 1495 1511	tumor resistance
R24	causes_or_contributes_to Arg1:T36 Arg2:T96	
R25	causes_or_contributes_to Arg1:T35 Arg2:T96	
R26	causes_or_contributes_to Arg1:T94 Arg2:T96	
T97	missed_disease_or_phenotypic_feature 1547 1553	tumors
R19	treats Arg1:T94 Arg2:T97	
R20	treats Arg1:T35 Arg2:T97	
R23	treats Arg1:T36 Arg2:T97	
R10	treats Arg1:T95 Arg2:T63	
T98	corrected_chemical 2468 2471;2473 2483	ACE inhibitors
R27	treats Arg1:T98 Arg2:T63	
R9	treats Arg1:T98 Arg2:T62	
R29	treats Arg1:T95 Arg2:T62	
R11	treats Arg1:T95 Arg2:T85	
R28	treats Arg1:T98 Arg2:T85	
R30	causes_or_contributes_to Arg1:T17 Arg2:T18	
R31	treats Arg1:T28 Arg2:T29	
R32	treats Arg1:T28 Arg2:T30	
R33	treats Arg1:T28 Arg2:T31	
T75	missed_chemical 1720 1723	HFD
R34	causes_or_contributes_to Arg1:T75 Arg2:T42	
R35	causes_or_contributes_to Arg1:T75 Arg2:T91	
R36	treats Arg1:T55 Arg2:T82	
T76	corrected_chemical 1898 1911	high-fat diet
R37	treats Arg1:T76 Arg2:T50	
T77	corrected_chemical 172 243	phosphorus-enriched, conventional, calcium-containing dialysis solution
R38	treats Arg1:T77 Arg2:T89	
R39	treats Arg1:T77 Arg2:T7	
R40	treats Arg1:T77 Arg2:T8	
